← All businessesHealthcare & Life Sciences / Pharmacies / Community pharmacy
Community Pharmacy With Its Freehold Shop In Central Southampton
Southampton, Hampshire, South EastIdentity protected
Available
About this business
A city-centre community pharmacy in Southampton, opened in 2023 and run by a team of 5. Most of the work is dispensing repeat prescriptions for people who live and work nearby, with over-the-counter medicines, health advice and walk-in services at the counter alongside. Turnover has held at about £820k a year since opening, while EBITDA has risen each year to £150k as buying and rotas were tightened. The freehold of the shop is part of the sale, so a buyer owns the premises outright instead of paying rent. The pharmacy could move if a buyer wished, though its current spot brings a good flow of passing trade.
Key investment highlights
- Freehold shop included in the sale
- EBITDA up from £114k to £150k since 2023
- Turnover steady at around £820k
- Passing trade from a city-centre street
Reason for sale
The owner is selling to concentrate on a larger pharmacy she runs elsewhere in Hampshire.
Nothing flagged on the two questions buyers ask first
No flagRevenue going backwards and one client being too much of it are the two things that end most deals in due diligence. Both are shown here up front, from the figures the seller supplied.
- Revenue directionNo flag
Turnover is flat year on year.
- 2023: baseline
- 2024 (-1.5%)
- 2025 (+2.0%)
- 2026 (-0.7%)
- Peak 2025 to latest 2026: -0.7%
4 years of turnover, 2023 to 2026, as supplied by the seller.
- Client concentrationNot stated
The seller has not declared what share of revenue the largest clients represent.
No declaration supplied. Client concentration cannot be derived from accounts.
EBITDA margin widened from 13.9% in 2023 to 18.3% in 2026.
These are observations from the supplied figures, not a view on whether this business is worth buying. Nothing here predicts an outcome.
Computing valuation...
What happens next
Submit an enquiry to the seller. Once they approve it, you sign a non-disclosure agreement and gain access to the information memorandum, the financials and a secure deal room with the seller.